secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0001104659-24-108078
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics receives Nasdaq deficiency notice for market value below $50M
--------------------------------------------------------------------------------

- Nasdaq notified Carisma on Oct 10, 2024 that MVLS fell below $50M minimum requirement.
- Company has 180 days, until April 8, 2025, to regain compliance by closing at $50M+ for 10 consecutive days.
- Failure to regain compliance may lead to delisting; company can appeal to a Nasdaq Hearing Panel.
- Carisma will monitor MVLS and evaluate options to meet Nasdaq listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/0001104659-24-108078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/tm2426043d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-108078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer